In the late 19th century, postmortem examinations demonstrated a possible relationship
between thrombotic occlusion of a coronary artery and myocardial infarction (MI). 1 …

Abstract BACKGROUND Cardiac troponin I (cTnI) and cardiac troponin T (cTnT)
determinations are fixtures in clinical practice and research. Cardiac troponin testing has …

Copies: This document is available on the website of the American College of Cardiology
(www. acc. org). For copies of this document, please contact Elsevier Inc. Reprint …

The 2021 American Heart Association/American College of Cardiology/American Society of
Echocardiography/American College of Chest Physicians/Society for Academic Emergency …

Laboratory diagnosis plays one of the key roles in the diagnosis of many diseases, including
cardiovascular diseases (CVD). The methods underlying the in vitro study of many CVD …

BACKGROUND Clinical performance of the novel high-sensitivity cardiac troponin I
(Siemens-hs-cTnI-Centaur) assay is unknown. We aimed to clinically validate the Siemens …

A novel enhanced chemiluminescent immunoassay (CLIA) for ultrasensitive and excellent
precisive determination of cardiac troponin I (cTnI) was reported. The method made full use …

Background How to select healthy reference subjects in deriving 99th percentiles for cardiac
troponin assays still needs to be clarified. To assist with global implementation of high …

Background: High-sensitivity cardiac troponin (hs-cTn) laboratory assays are used to rule
out myocardial infarction (MI) on presentation, but prolonged result turnaround times can …

Chemiluminescence immunoassay (CLIA) has always been a great challenge in detecting
cardiac troponin I (cTnI) in whole blood samples without centrifugation because of the …